Molina Healthcare, Inc.
NYSE:MOHMedical - Healthcare Plans
-$4.68 today
- Market cap
- $10.78B
- Beta
- 0.80
- P/E (TTM)
- 53.0
- EPS (TTM)
- $3.69
Volume 1.33M
Average 1.37M
MOH EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Molina Healthcare, Inc.NYSE: MOH
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA declines year over year
Q3 FY2026 EBITDA of $144M fell 20.9% year over year, ahead of the -78.1% change in trailing-twelve-month EBITDA. Sequentially, it fell 22.2% from the prior quarter. Over 3 fiscal years it compounded at -10.2% a year.
Context
- EBITDA amounted to 2.1% of revenue in FY2025, down 2.5 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 12 analysts of $684.72M (-29.8%) for the fiscal year ending Dec 2026, a step up from the -48.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $144M-22.2% QoQ
- Last fiscal yearDec 2025
- $976M-48.4% YoY
- LTMSep 2026
- $333M-78.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -20.9% | +207.4% | +228.3 pp |
| 1 year | -48.4% | -29.8% | +18.6 pp |
| 3-year CAGR | -10.2% | +8.3% | +18.5 pp |
| 5-year CAGR | +13.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 976M USD
- Year-over-year change
- -48.4%
- 4-year CAGR
- -3.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 976M | -48.4% |
| FY2024 | 2024-12-31 | 1.89B | +8.5% |
| FY2023 | 2023-12-31 | 1.74B | +29.3% |
| FY2022 | 2022-12-31 | 1.35B | +19.8% |
| FY2021 | 2021-12-31 | 1.13B | — |
EBITDA vs competitors
How MOH compares with its peers on the latest reported figures
- MOH's LTM Sep 2026 EBITDA of $333M is the 6th highest of the 8 companies compared; the peer median is $3.24B.
- Its year-over-year change of -78.1% is the 7th highest of 8, against a peer median of +1.2%.
- EBITDA amounts to 0.8% of revenue for MOH, versus a peer median of 4.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $27.99B | -8.3% | -10.2% | 6.2% | |
| LTM Sep 2026 | $12.53B | +1.2% | +0.7% | 4.4% | |
| LTM Sep 2026 | $8.88B | -11.4% | -1.6% | 4.4% | |
| LTM Sep 2026 | $3.24B | +4.5% | -15.4% | 2.1% | |
| LTM Jun 2026 | $633.7M | +751.9% | — | 4.1% | |
| LTM Sep 2026 | $333M | -78.1% | -10.2% | 0.8% | |
| LTM Mar 2026 | $66.42M | +265.7% | — | 1.6% | |
| LTM Jun 2026 | -$2.73B | -158.1% | — | 1.4% | |
| Peer median (excluding MOH) | $3.24B | +1.2% | -5.9% | 4.1% | |
Competitors are the stored peer set for MOH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 27.77B | 31.97B | 34.07B | 40.65B | 45.43B |
| Cost of Revenue | 24.49B | 28.05B | 29.74B | 35.91B | 41.35B |
| Gross Profit | 3.28B | 3.93B | 4.33B | 4.74B | 4.08B |
| Gross Margin | 11.8% | 12.3% | 12.7% | 11.7% | 9.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 2.07B | 2.31B | 2.46B | 2.74B | 3.01B |
| Operating Expenses | 2.26B | 2.55B | 2.76B | 3.03B | 3.29B |
| Depreciation & Amortization | 131M | 176M | 171M | 186M | 195M |
| EBITDA | 1.13B | 1.35B | 1.74B | 1.89B | 976M |
| EBITDA Margin | 4.1% | 4.2% | 5.1% | 4.7% | 2.1% |
| Operating Income | 1.02B | 1.38B | 1.57B | 1.71B | 781M |
| Operating Margin | 3.7% | 4.3% | 4.6% | 4.2% | 1.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 120M | 110M | 109M | 118M | 192M |
| Other Income / Expenses | (145M) | (318M) | (109M) | (118M) | (192M) |
| Income Before Tax | 875M | 1.06B | 1.46B | 1.59B | 589M |
| Pre-Tax Margin | 3.2% | 3.3% | 4.3% | 3.9% | 1.3% |
| Income Tax Expense | 216M | 271M | 373M | 410M | 117M |
| Net Income | 659M | 792M | 1.09B | 1.18B | 472M |
| Net Margin | 2.4% | 2.5% | 3.2% | 2.9% | 1.0% |
| EPS (Basic) | 11.40 | 13.70 | 18.71 | 20.52 | 8.93 |
| EPS (Diluted) | 11.25 | 13.54 | 18.78 | 20.42 | 8.92 |
| Weighted Avg Shares | 57.8M | 57.8M | 58.1M | 57.4M | 50.79M |
| Weighted Avg Shares (Diluted) | 58.6M | 58.5M | 58.1M | 57.7M | 50.79M |
Molina Healthcare, Inc.
NYSE:MOH
Intrinsic Alpha fair value
Locked
Current Price
$206.56
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.